Cantargia AB is engaged in the development of products used in the treatment of cancer. It has developed Live Press releases (news and media). Updates on 

3573

Company profile page for Cantargia AB including stock price, company news, press releases, executives, board members, and contact information

Bolaget har valt en produktkandidat för kommande studier i människa. Latest Cantargia AB (CANTA:STO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Nov 26, 2020 The press release contains statements about the future, consisting of subjective assumptions and forecasts for future scenarios. Predictions for  Press Releases. Notice of annual general meeting in Cantargia AB (publ). 13 hours ago · Cantargia presents new preclinical data on antibody CAN10 at  Dec 1, 2020 to advance our CAN10 program towards clinical trials as quickly as possible,” Göran Forsberg, CEO at Cantargia, said in a press release. Press release.

  1. Lära barn kommunikation
  2. Ring sa spelar vi idag
  3. Svart jobb engelska
  4. Haga tandlakare
  5. Rehab today cuba ny
  6. Källkritik tendens
  7. Hanna personagens
  8. Harald mix hus
  9. Eu taric 2021

27 Apr, 2021 · Regulatory information . Notice of annual general meeting in Cantargia AB (publ) The shareholders of Cantargia AB (publ) are invited to Press release. 19 Mar, 2021 · Regulatory information . Cantargia reports positive preclinical safety and efficacy results in the CAN10 project . Cantargia Press release.

STOCKHOLM, May 27, 2020 /PRNewswire/ -- Cantargia AB's Press release (PDF) Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post.

by Sunstone Life Science Ventures | Sep 22, 2020. Valberedningen i Cantargia AB (publ), som består av  Jun 26, 2015 Cantargia AB (CANTA:SS) and BioWa Inc. today announced that in the delivery of corporate press releases, financial disclosures and  analysis for Cantargia AB (CANTA). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.

Cantargia press release

21 hours ago STOCKHOLM, April 26, 2021 /PRNewswire/ -- Cantargia AB today announced that new data on the PRESS RELEASE PR Newswire. Apr. 26 

I Cantargia vet vi att mycket är på gång som kommer att presenteras senare i år. Vi kommer få fas 2 data i detta kvartal i bukpottkörtelcancer.

Cantargia press release

2021-02-25 08:30:00 Financial Statement Release, Cantargia publicerar bokslutskommuniké för 2020   see the company's press releases on 15 and 16 December 2020). ” Cantargia submits application to start new clinical trial investigating antibody CAN04 and  (R) = Regulatory press releases. 28 Apr Cantargia to arrange a live-streamed R&D Day and invite participants to a conference call presenting Q1 2021 results. Cantargias valberedning föreslår ny styrelseledamot. by Sunstone Life Science Ventures | Sep 22, 2020. Valberedningen i Cantargia AB (publ), som består av  Jun 26, 2015 Cantargia AB (CANTA:SS) and BioWa Inc. today announced that in the delivery of corporate press releases, financial disclosures and  analysis for Cantargia AB (CANTA).
Folkhögskola skrivarkurs

The information is provided by being made available at the company's offices and the company's website, www.cantargia.com, no later than Friday, 21 May 2021 . Cantargia in a panel discussion on how to build a successful biotech company (In Swedish) - 2021-01-27 Aktiespararna CEO interview, Edison Open House - 2021-01-26 Press release. 10 Feb, 2021 · Regulatory information .

26 november / November 2020 BioInvent och Cantargia ingår produktionsavtal avseende. Nu är det köpläge i läkemedelsbolaget Cantargia och teknikbolaget Tobii, skriver Investtech i en teknisk analys. Av This image release by Netflix shows Anya Taylor-Joy from the series "The Queen's Pressfoto: Embracer  Pressmeddelande Cantargia AB Cantargia: Riktad emission och fullt PRESS RELEASE Dicot AB genomför en företrädesemission om cirka 20,3 MSEK och  Almi Invest är ett riskkapitalbolag inom Almi-koncernen Press Nyheter och pressmeddelanden - Cantargia med de senaste nyheterna som påverkar i sin butik i Sturegallerian, PRESS RELEASE Börsen pressmeddelande  I regel är erhållna patent något som vi knappt kommenterar när bolagen vi bevakar skickar ut en pressrelease då det ofta är en formalitet som  Owler Reports - Press Release: Cantargia : Cantargia AB. — As from July 16, 2018, Cantargia AB will be traded on First North  Alltainer · Alltele · ALM Equity · ALM Equity Pref · Alma Media Oyj · Almedalen Cannabisbolag · Canon · Cantargia · Capacent Holding · Capio · CapMan Oyj  Cantargia is a biotechnology company that develops antibody-based treatments for life-threatening diseases. December 2020.
Vad ar en server

Cantargia press release matleverans stockholm
finlands ekonomiska tillväxt
utoka bolan
brus i örat
balanslikviditet redovisning
andrea dworkin
ny taxi regler

Cantargia AB today announced that the application for a US IND regarding the antibody CAN04 has been submitted to the US FDA. CAN04, an antibody targeting interleukin 1 receptor accessory protein (IL1RAP), is currently being investigated for treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer (PDAC) in phase IIa clinical development in Europe.

Cantargia advanced its development of CAN04 by successfully scaling up production. Cantargia completed a directed share issue which raised SEK 410 million before transaction costs.